Phase II study of antineoplastons A10 and AS2-1 in children with primary malignant brain tumors
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary)
- Indications Brain cancer
- Focus Therapeutic Use
- Sponsors Burzynski Research Institute
- 26 Feb 2017 Status changed from completed to discontinued.
- 12 Aug 2005 New trial record.